Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2843
Source ID: NCT01486940
Associated Drug: Insulin Detemir
Title: Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 1
Interventions: DRUG: insulin detemir|DRUG: insulin aspart|DRUG: insulin NPH|DRUG: human soluble insulin
Outcome Measures: Primary: HbA1c (glycosylated haemoglobin) | Secondary: Intra-subject variation in home measured blood glucose (3-point blood glucose profiles)|8-point blood glucose profiles|Incidence of self-recorded hypoglycaemic episodes|Incidence of adverse events
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 598
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2002-03
Completion Date: 2002-10
Results First Posted:
Last Update Posted: 2017-01-27
Locations: Novo Nordisk Investigational Site, Junin, Argentina|Novo Nordisk Investigational Site, Moron, Argentina|Novo Nordisk Investigational Site, Varazdin, 42 000, Croatia|Novo Nordisk Investigational Site, Hradec Kralove, 50036, Czech Republic|Novo Nordisk Investigational Site, Liberec, 46001, Czech Republic|Novo Nordisk Investigational Site, Plzen - Lochotin, 30460, Czech Republic|Novo Nordisk Investigational Site, Praha 10, 10034, Czech Republic|Novo Nordisk Investigational Site, Praha 2, 12000, Czech Republic|Novo Nordisk Investigational Site, Praha 4, 140 00, Czech Republic|Novo Nordisk Investigational Site, Praha 5, 150 18, Czech Republic|Novo Nordisk Investigational Site, Hillerød, 3400, Denmark|Novo Nordisk Investigational Site, Hjørring, 9800, Denmark|Novo Nordisk Investigational Site, Holbæk, 4300, Denmark|Novo Nordisk Investigational Site, København, 2400, Denmark|Novo Nordisk Investigational Site, Køge, 4600, Denmark|Novo Nordisk Investigational Site, Silkeborg, 8600, Denmark|Novo Nordisk Investigational Site, Slagelse, 4200, Denmark|Novo Nordisk Investigational Site, Svendborg, 5700, Denmark|Novo Nordisk Investigational Site, Århus C, 8000, Denmark|Novo Nordisk Investigational Site, Kemi, 94100, Finland|Novo Nordisk Investigational Site, Kokkola, 67200, Finland|Novo Nordisk Investigational Site, Kuopio, 70210, Finland|Novo Nordisk Investigational Site, Oulu, FI-90220, Finland|Novo Nordisk Investigational Site, Pärnu, 80010, Finland|Novo Nordisk Investigational Site, Rovaniemi, 96400, Finland|Novo Nordisk Investigational Site, Viljandi, 71024, Finland|Novo Nordisk Investigational Site, Angers, France|Novo Nordisk Investigational Site, GRENOBLE cedex, 38043, France|Novo Nordisk Investigational Site, Lille, 59037, France|Novo Nordisk Investigational Site, Lorient, 56322, France|Novo Nordisk Investigational Site, MONTPELLIER cedex 5, 34295, France|Novo Nordisk Investigational Site, Mougins, 06250, France|Novo Nordisk Investigational Site, Narbonne, 11108, France|Novo Nordisk Investigational Site, Paris Cedex 10, 75475, France|Novo Nordisk Investigational Site, Paris, 75014, France|Novo Nordisk Investigational Site, Paris, 75877, France|Novo Nordisk Investigational Site, Poitiers, 86000, France|Novo Nordisk Investigational Site, Athens, GR-10552, Greece|Novo Nordisk Investigational Site, Athens, GR-115 27, Greece|Novo Nordisk Investigational Site, Athens, GR-11527, Greece|Novo Nordisk Investigational Site, Alessandria, Italy|Novo Nordisk Investigational Site, Asti, 14100, Italy|Novo Nordisk Investigational Site, Bari, 70100, Italy|Novo Nordisk Investigational Site, Bergamo, 24127, Italy|Novo Nordisk Investigational Site, Catania, 95124, Italy|Novo Nordisk Investigational Site, Catania, 95126, Italy|Novo Nordisk Investigational Site, Genova, 16132, Italy|Novo Nordisk Investigational Site, Lucca, 55100, Italy|Novo Nordisk Investigational Site, Milano, 20132, Italy|Novo Nordisk Investigational Site, Padova, 35143, Italy|Novo Nordisk Investigational Site, Prato, 59100, Italy|Novo Nordisk Investigational Site, Ravenna, 48121, Italy|Novo Nordisk Investigational Site, Roma, 00161, Italy|Novo Nordisk Investigational Site, Torino, 10126, Italy|Novo Nordisk Investigational Site, Skopje, 1000, Macedonia, The Former Yugoslav Republic of|Novo Nordisk Investigational Site, Arendal, 4841, Norway|Novo Nordisk Investigational Site, Gjettum, 1346, Norway|Novo Nordisk Investigational Site, Gjøvik, NO-2819, Norway|Novo Nordisk Investigational Site, Kongsberg, NO-3602, Norway|Novo Nordisk Investigational Site, Kongsvinger, 2212, Norway|Novo Nordisk Investigational Site, Kristiansand S, 4604, Norway|Novo Nordisk Investigational Site, Rådal, 5235, Norway|Novo Nordisk Investigational Site, Bydgoszcz, 85-094, Poland|Novo Nordisk Investigational Site, Bydgoszcz, 85-822, Poland|Novo Nordisk Investigational Site, Gdansk, 80-211, Poland|Novo Nordisk Investigational Site, Krakow, 31-501, Poland|Novo Nordisk Investigational Site, Lodz, 90-030, Poland|Novo Nordisk Investigational Site, Lublin, 20-718, Poland|Novo Nordisk Investigational Site, Szczecin, 71-455, Poland|Novo Nordisk Investigational Site, Timisoara, 300736, Romania|Novo Nordisk Investigational Site, Moscow, 117036, Russian Federation|Novo Nordisk Investigational Site, Moscow, 125315, Russian Federation|Novo Nordisk Investigational Site, Kosice, 043 80, Slovakia|Novo Nordisk Investigational Site, Moldava nad Bodvou, 045 01, Slovakia|Novo Nordisk Investigational Site, Falun, 791 82, Sweden
URL: https://clinicaltrials.gov/show/NCT01486940

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress